Market Tracker

12/13 5:15pm ET

Novo Nordisk A/S (NYSE:NVO)

53.39
Delayed Data
As of 4:02pm ET
 +0.07 / +0.13%
Today’s Change
32.83
Today|||52-Week Range
53.48
+48.88%
Year-to-Date

Today’s Trading

Previous close53.32
Today’s open53.17
Day’s range53.03 - 53.48
Volume2,070,383
Average volume (3 months)1,860,976
Market cap$103.1B
Data as of 4:02pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.52%
Revenue growth (last year)+3.81%
P/E ratio21.7
Price/Sales5.48
Price/Book20.44

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+1.18+1.36%
ABTAbbott Laboratories-0.64-1.15%
GSKGlaxoSmithKline+0.06+0.17%
BMYBristol-Myers Squibb+0.19+0.30%
Data as of 4:02pm ET, 12/13/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.55
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts